Opioids
With the opioid crisis harming families and communities, IHA supports efforts to limit access to those powerful painkillers, coordinate response among providers and encourage individual recovery.
Illinois’ Opioid Crisis
Opioid-related overdose deaths, 2022
Deaths involving synthetic opioids (mainly fentanyl), 2022
Rate increase in opioid overdose deaths, 2018-2022
Source: Illinois Dept. of Public Health
Funding Available for FQHCs and RHCs with X-Waivered Staff
HRSA has launched an effort to improve access to substance use disorder treatment, HRSA DATA 2000 Waiver Training Payment Program for Buprenorphine-Trained Clinicians.
IHA Summary: President Signs Federal Opioid Package
Today, President Donald Trump signed the bipartisan SUPPORT for Patients and Communities Act, H.R. 6 (115).
Opioid Guidelines - Long Version
IHA collaborated with the Illinois College of Emergency Physicians (ICEP) to develop informational guidelines for treating patients with acute and chronic pain in the emergency department (ED).
Opioid Guidelines - Executive Summary
IHA and ICEP’s informational guidelines on treating patients with acute and chronic pain in the ED are also available in an executive summary. Both versions address common clinical scenarios.
IDPH Naloxone Standing Order
Illinois' Naloxone Standing Order acts as a prescription and allows pharmacists, pharmacies, and opioid overdose education and naloxone distribution programs to obtain and/or distribute naloxone.
CDC Guidelines on Opioid Use
In March 2016, the Centers for Disease Control and Prevention issued guidelines and recommendations on opioid use to treat chronic, non-cancer pain.
HB1 PA 99-0480
Effective Sept. 9, 2015, a landmark law in Illinois addresses opioid abuse and its illegal use by amending nearly 25 state laws, including the Hospital Licensing and Controlled Substance Act.